The i31-SLNB Identifies Patients with Cutaneous Melanoma Who Have Less than 5% Risk of SLN Positivity while the CP-GEP does not. J of Skin [Internet]. 2025 Mar. 17 [cited 2026 Apr. 17];9(2):s563. Available from: https://skin.dermsquared.com/skin/article/view/3289